lercanidipine has been researched along with Atherogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, H; Jiang, XJ; Peng, M; Wu, HY; Yang, Y; Zhang, HM; Zou, YB | 1 |
| Fomin, VV; Svistunov, AA | 1 |
1 review(s) available for lercanidipine and Atherogenesis
| Article | Year |
|---|---|
[Lerkanidipin: evolution of dihydropyridine calcium antagonists continues].
Topics: Age Factors; Aged; Atherosclerosis; Blood Pressure; Calcium Channel Blockers; Carotid Intima-Media Thickness; Dihydropyridines; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Pharmacovigilance; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
1 other study(ies) available for lercanidipine and Atherogenesis
| Article | Year |
|---|---|
Can lercanidipine improve renal function in patients with atherosclerotic renal artery stenosis undergoing renal artery intervention?
Topics: Adult; Aged; Angioplasty, Balloon; Antihypertensive Agents; Atherosclerosis; Blood Pressure Monitoring, Ambulatory; Cohort Studies; Creatinine; Dihydropyridines; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Pulse Wave Analysis; Renal Artery Obstruction; Stents; Treatment Outcome | 2015 |